Tags » Pharmaceuticals

Childbirth In The Age Of Addiction: New Mom Worries About Maintaining Sobriety
















When she was in her early 20s, Nicole Veum says, she made a lot of mistakes.

“I was really sad and I didn’t want to feel my feelings,” she said. 1,482 more words

Public Health

Activated Charcoal Tablets Market Segmentation Application, Technology & Market Analysis Research Report 2025

14th November 2018: The global Activated Charcoal Tablets Market will witness profound growth in forecast period. Market growth is governed by activated charcoal’s medical uses wherein activated charcoal is used to treat poisonings and oral overdoses following oral ingestion. 280 more words

Pharmaceuticals

Thalassemia Market Estimates, Share, Vendors, Growth Rate Forecast 2016-2022

14 Nov 2018: The global Thalassemia Market size is predicted to value at USD 3.53 billion by 2022, during the forecast period. The market is subject to observe a substantial growth due to the rise in occurrence of thalassemia diseases, and high-end demand for global cure. 644 more words

Pharmaceuticals

Erectile Dysfunction Drugs Market Insights | Emerging Trends & Demand | Forecast To 2022

The global Erectile Dysfunction Drugs Market size is expected to value at USD 3.2 billion by 2022. The market is subject to witness a substantial growth due to the rising health awareness among general population and increase in initiatives undertaken by local governments and private bodies to promote use of erectile dysfunction drugs. 684 more words

a polite smile will do

simply use some tape

in the case it often

melts off of your face

at first you opened the door for me gently… 117 more words

PreveCeutical Announces LOI with Crushedit LLC to Supply CBD Isolate for Expected Sale Proceeds of $16.25 Million

Vancouver, British Columbia–(Newsfile Corp. – November 13, 2018) – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), (the “Company” or “PreveCeutical“) announces that it has entered into a non-binding letter of intent dated November 9, 2018 (the “LOI“) with Crushedit LLC (“Crushedit“), whereby PreveCeutical’s newly created Cannabis Division (see news release dated July 24, 2018) will supply Crushedit with a minimum of 2,500 kilograms of Cannabidiol (“CBD“) isolate over a 12 month period at a purchase price of CAD $6,500.00 per kilogram, for aggregate sale proceeds of at least CAD $16,250,000 (the “Transaction“). 843 more words